Theraclion's Stock Soars 14% After Nearly Touching Its 0.45€ Support
The stock of the French medtech company specializing in therapeutic ultrasound is trading at 0.549€ this Tuesday, April 28, 2026, marking a 14.38% increase from the previous day's close. This rebound comes after a challenging quarter, during which the stock fell more than 35% over three months, amidst a generally stable Parisian market environment.
A Technical Rebound After Several Weeks of Decline
Theraclion's stock is trading at 0.549€ mid-session, after closing Monday at 0.48€. This 14.38% increase is the most significant movement in seven days, with a weekly performance of +14.26%. Despite this rebound, the medium-term dynamics remain fragile: the price is significantly below its 50-day moving average (0.61€) and its 200-day moving average (0.60€), both of which now act as resistance levels. The RSI, at 37, indicates a stock still close to the oversold zone, which partly explains the magnitude of today's bullish movement. Regarding the Bollinger Bands, the price is at 47% of the band, between the lower bound at 0.45€ and the upper bound at 0.66€, indicating a median positioning without extreme signals. The technical support identified at 0.45€ has played its role in recent sessions, with the stock rebounding near this level. The resistance to watch is at 0.68€.
A Contrasting Annual Trajectory and Upcoming Deadlines
Over the past year, Theraclion has shown a performance of +285.3%, reflecting a strong revaluation of the stock between spring 2025 and early 2026. However, the correction observed over the last three months (-35.29%) puts this surge into perspective and illustrates the volatility inherent in this small-cap medical device sector stock. The monthly volatility, measured at 26.77%, confirms the extent of recent fluctuations. A negative beta of -0.31 also indicates a weak correlation with major indices, making the stock less dependent on the general market trend. On the financial calendar, two important events are scheduled: the general assembly on Thursday, June 18, 2026, and the publication of the half-yearly results for 2026 on Wednesday, October 14, 2026. These events will provide new insights into the financial situation and progress of the company's projects. During the session, the CAC 40 is up by 0.37% at 8,172 points, while the SBF 120 gains 0.36%, offering a relatively supportive market environment for Parisian stocks in the middle of the day.
